Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Blood Pressure Determinants of Cerebral White Matter Hyperintensities and Microstructural Injury: UK Biobank Cohort Study

Wartolowska KA. and Webb AJS., (2021), Hypertension

Patient-reported outcome measures (PROMs) as proof of treatment efficacy

Kluzek S. et al, (2021), BMJ Evidence Based Medicine

Progression of Beat-to-Beat Blood Pressure Variability Despite Best Medical Management

Webb AJS. et al, (2020), Hypertension

Midlife blood pressure is associated with the severity of white matter hyperintensities: analysis of the UK Biobank cohort study

WARTOLOWSKA K. and WEBB A., (2020), European Heart Journal

A Higher Grey Matter Density in the Amygdala and Midbrain Is Associated with Persistent Pain Following Total Knee Arthroplasty

Lewis GN. et al, (2020), Pain Medicine

Reply to Banik.

Kjær SW. et al, (2020), Pain, 161, 1939 - 1940

Neuromodulation: more than a placebo effect?

Kjær SW. et al, (2020), Pain, 161, 491 - 495

Pain, placebo, and test of treatment efficacy: a narrative review

Vase L. and Wartolowska K., (2019), British Journal of Anaesthesia, 123, e254 - e262

Response to "Treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71).

Wanigasekera V. et al, (2019), Br J Anaesth, 123, e166 - e171

The nocebo effect as a source of bias in the assessment of treatment effects

Wartolowska K., (2019), F1000Research, 8, 5 - 5

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

Rooshenas L. et al, (2019), Journal of Clinical Epidemiology, 106, 108 - 120

Nocebo as a source of bias in the assessment of treatment effect

Wartolowska K., (2019), F1000Research, 8, 5 - 5

An observational study showed that explaining randomization using gambling-related metaphors and computer-agency descriptions impeded randomized clinical trial recruitment

Jepson M. et al, (2018), Journal of Clinical Epidemiology, 99, 75 - 83

The use of placebos in controlled trials of surgical interventions: a brief history

Wartolowska KA. et al, (2018), Journal of the Royal Society of Medicine, 111, 177 - 182

Borderline Regulation of Stem Cell Technologies: Therapies, Devices and Combination Products

Smith J. et al, (2018)

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging

Wanigasekera V. et al, (2018), British Journal of Anaesthesia, 120, 299 - 307

Blinding in trials of interventional procedures is possible and worthwhile

Wartolowska K. et al, (2018), F1000Research, 6, 1663 - 1663

Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial

Beard DJ. et al, (2018), The Lancet, 391, 329 - 338

A meta-analysis of temporal changes of response in the placebo arm of surgical randomized controlled trials: an update

Wartolowska KA. et al, (2017), Trials, 18

Electrical shavers and splashed saline – how blinding has been achieved in surgical placebo-controlled trials

Wartolowska K., (2017)

Load More

Include forthcoming?